NuvoAir

Last updated on

Visit website

NHS Problem

Respiratory disease is the third biggest cause of death in England and accounts for 1.1 million hospital admissions costing the NHS and wider economy £11 billion per year. Despite outcomes improving for other health conditions such as cancer and heart disease, respiratory health outcomes have remained unchanged over the last 10 years. A fast and accurate diagnosis is essential to addressing this challenge. Unfortunately, the spirometry testing required to diagnose respiratory conditions has become increasingly difficult for the NHS to access, leading to delayed or inaccurate diagnoses and undoubtedly contributing to the UK having one of the highest mortality rates for respiratory disease in Europe. 

The Solution

NuvoAir Home is a technology-enabled service which boosts access to quality spirometry testing using a convenient assessment of lung health performed digitally and remotely from the individual’s home. Using hand-held spirometry and symptom scoring, individuals are coached to produce multiple tests which are summarised by experts in a clear report. No reliance on NHS equipment, busy clinicians or data from only one test – just high-quality insights for diagnosis and fast. 

Impact

  • Clinic-quality spirometry achieved from home in >80% of patients 
  • Reduced wait for spirometry and time to treatment optimisation/onward referral 
  • Improved access to spirometry in the hard-to-reach/DNA cohort 
  • Improved awareness for the user of the impact of triggers, medications and exacerbations on lung health  

Long-term outcomes (data collection in process):

  • Faster disease control resulting in a reduction of steroid use (and associated co-morbidities) and emergency healthcare use 
  • Reduction in over-use of short-acting bronchodilators (a proxy for uncontrolled respiratory disease) 
  • Reduction in inappropriate referrals to secondary care services 
  • Faster time to respiratory consultant review and/or assessment for biologics (in asthma) 
  • Reduction in the time and cost of attending appointments (patient) 
  • Reduced risk of emergency or catastrophic events for unstable patients on waiting lists (as these people can be surfaced, triaged and prioritised)